SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Concentrix Corp (CNXC) (CIK 0001803599) (CNXC) — Oct 26, 2020

Concentrix Corp (CNXC) (CIK 0001803599)
Date: Oct. 26, 2020 · CIK: 0001803599 · Accession: 0000000000-20-010121

AI Filing Summary & Sentiment

File numbers found in text: 001-39494

Date
October 26, 2020
Author
Not clearly detected
Form
UPLOAD
Company
Concentrix Corp (CNXC) (CIK 0001803599)

Letter

United States securities and exchange commission logo October 26, 2020 Christopher Caldwell Chief Executive Officer Concentrix Corp 44111 Nobel Drive Fremont, CA 94538 Re:Concentrix Corp Amendment No. 1 to Draft Registration Statement on Form 10 Filed on October 13, 2020 File No. 001-39494 Dear Mr. Caldwell: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response and any amendment you may file in response to these comments, we may have additional comments. Amendment No. 1 to Registration Statement on Form 10 filed October 13, 2020 Risk Factors, page 18 1.We note that your forum selection provision in your bylaws identifies the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation, including any "derivative action." Please revise your registration statement to clearly describe any risks or other impacts on investors. Risks may include, but are not limited to, increased costs to bring a claim and that these provisions can discourage claims or limit investors' ability to bring a claim in a judicial forum that they find favorable. Also disclose whether the provision applies to actions arising under the Securities Act or Exchange Act. In that regard, we note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or

FirstName LastNameChristopher Caldwell Comapany NameConcentrix Corp October 26, 2020 Page 2 FirstName LastName Christopher Caldwell Concentrix Corp October 26, 2020 Page 2 liability created by the Securities Act or the rules and regulations thereunder. If the provision applies to Securities Act claims, please also revise your offering circular to state that there is uncertainty as to whether a court would enforce such provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. If the provision does not apply to actions arising under the Securities Act or Exchange Act, please also ensure that the exclusive forum provision in the governing documents states this clearly, or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Securities Act or Exchange Act. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Adam Phippen at (202) 551-3336 or Lyn Shenk at (202) 551-3380 if you have questions regarding comments on the financial statements and related matters. Please contact Daniel Morris at (202) 551-3314 or Mara Ransom at (202) 551-3264 with any other questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Allison Leopold Tilley, Esq.

Show Raw Text
United States securities and exchange commission logo
October 26, 2020
Christopher Caldwell
Chief Executive Officer
Concentrix Corp
44111 Nobel Drive
Fremont, CA 94538
Re:Concentrix Corp
Amendment No. 1 to Draft Registration Statement on Form 10
Filed on October 13, 2020
File No. 001-39494
Dear Mr. Caldwell:
            We have reviewed your filing and have the following comments.  In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response and any amendment you may file in response to these
comments, we may have additional comments.
Amendment No. 1 to Registration Statement on Form 10 filed October 13, 2020
Risk Factors, page 18
1.We note that your forum selection provision in your bylaws identifies the Court of
Chancery of the State of Delaware as the exclusive forum for certain litigation, including
any "derivative action." Please revise your registration statement to clearly describe any
risks or other impacts on investors. Risks may include, but are not limited to, increased
costs to bring a claim and that these provisions can discourage claims or limit investors'
ability to bring a claim in a judicial forum that they find favorable. Also disclose whether
the provision applies to actions arising under the Securities Act or Exchange Act. In that
regard, we note that Section 27 of the Exchange Act creates exclusive federal jurisdiction
over all suits brought to enforce any duty or liability created by the Exchange Act or the
rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent
jurisdiction for federal and state courts over all suits brought to enforce any duty or

 FirstName LastNameChristopher Caldwell
 Comapany NameConcentrix Corp
 October 26, 2020 Page 2
 FirstName LastName
Christopher Caldwell
Concentrix Corp
October 26, 2020
Page 2
liability created by the Securities Act or the rules and regulations thereunder. If the
provision applies to Securities Act claims, please also revise your offering circular to state
that there is uncertainty as to whether a court would enforce such provision and that
investors cannot waive compliance with the federal securities laws and the rules and
regulations thereunder. If the provision does not apply to actions arising under the
Securities Act or Exchange Act, please also ensure that the exclusive forum provision in
the governing documents states this clearly, or tell us how you will inform investors in
future filings that the provision does not apply to any actions arising under the Securities
Act or Exchange Act.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            You may contact Adam Phippen at (202) 551-3336 or Lyn Shenk at (202) 551-3380 if
you have questions regarding comments on the financial statements and related matters.  Please
contact Daniel Morris at (202) 551-3314 or Mara Ransom at (202) 551-3264 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       Allison Leopold Tilley, Esq.